آخر الأخبار لـ ARKG

ARK Genomic Revolution ETF (ARKG) advanced 4.27% to $50.06 on August 25, with AUM of approximately $1.6 billion. The fund has now gained 65.72% year-to-date, making the day's move incremental relative to a strong broader run. ARKG is an actively managed ETF focused on companies involved in genomics, gene editing, and related biotechnology.

ARK Genomic Revolution ETF closed at $47.73 on August 19, gaining 10.46% on the day, with AUM of approximately $1.56 billion. The fund tracks genomics and biotechnology equities. The single-day move extends a year-to-date gain of 49.15%, making it one of the stronger performers in the thematic equity space in 2025.